Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis (NCT03327909) | Clinical Trial Compass
CompletedNot Applicable
Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis
United States131 participantsStarted 2018-07-16
Plain-language summary
For patients with kidney failure requiring hemodialysis treatment, sometimes the blood pressure will drop too low during dialysis. In an effort to prevent that from occurring, patients are frequently told to skip doses of their blood pressure medications. However, whether this actually prevents blood pressure drops during dialysis, and whether it may cause more uncontrolled high blood pressure is unknown. TAKE-HOLD will study the effect of taking or holding blood pressure medication on blood pressure for patients on hemodialysis.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 18 years
✓. On in-center thrice weekly hemodialysis
✓. Dialysis start time in the morning
✓. Taking at least one antihypertensive medication
Exclusion criteria
✕. Initiation of hemodialysis within previous 90 days
✕. Inability to provide informed consent
✕. Currently participating in another clinical trial (intervention study)
✕. \>2 unexcused missed dialysis sessions in the previous 30 days